15:35 , Jul 27, 2018 |  BC Week In Review  |  Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

Sangamo Therapeutics Inc. (NASDAQ:SGMO) will acquire CAR Treg therapy company TxCell S.A. (Euronext:TXCL), accelerating its immunology strategy by two years, according to a presentation on July 23. Sangamo expects to be the first company to...
22:49 , Jul 23, 2018 |  BC Extra  |  Company News

Sangamo acquiring TxCell, accelerates CAR Treg development

Sangamo Therapeutics Inc. (NASDAQ:SGMO) will acquire CAR Treg therapy company TxCell S.A. (Euronext:TXCL), accelerating its immunology strategy by two years, according to a presentation on Monday. Sangamo expects to be the first company to bring...
19:58 , Jul 13, 2018 |  BC Week In Review  |  Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

Microbiome company Nextbiotix S.A.S. (Dijon, France) raised €7 million ($8.1 million) in a series A round led by new investor Auriga Partners. Fellow new investors Sofimac Innovation, Cap Innov'Est, INRA and Biocodex also participated. Nextbiotix...
19:55 , Jul 5, 2018 |  BC Extra  |  Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

Microbiome company Nextbiotix S.A.S. (Dijon, France) raised €7 million ($8.1 million) in a series A round led by Auriga Partners. Sofimac Innovation, Cap Innov'Est, INRA and Biocodex also participated. Nextbiotix plans to advance lead candidate...
05:39 , Jan 19, 2018 |  BC Week In Review  |  Financial News

Pherecydes raises €8.7M series B

Anti-infectives company Pherecydes Pharma S.A. (Romainville, France) raised €8.7 million ($10.6 million) in a series B round led by new investor GO Capital on Jan. 16. New investors Omnes Capital and Fa Dièse and other...
05:17 , Mar 31, 2017 |  BC Week In Review  |  Financial News

Nosopharm completes venture financing

Antibiotic company Nosopharm S.A.S. (Nimes, France) raised €2.4 million ($2.6 million) in a venture round from new investors Auriga Partners, Kreaxi and Alto Invest and existing investors on March 28. Nosopharm S.A.S. , Nimes, France ...
00:37 , Jun 24, 2015 |  BC Extra  |  Financial News

Financial tracks

MPM Capital hired Briggs Morrison as a managing director. Oncology-focused MPM portfolio company Syndax Pharmaceuticals Inc. (Waltham, Mass.) hired Morrison as CEO earlier this month after he stepped down as CMO and EVP of global...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

CoLucid completes venture financing

CoLucid Pharmaceuticals Inc. , Durham, N.C.   Business: Neurology   Date completed: 2015-01-13   Type: Venture financing   Raised: $37.1 million   Investors: TVM Capital; Novo Ventures; Auriga Partners; Pappas Ventures; Domain Associates; Care Capital;...
02:28 , Jan 14, 2015 |  BC Extra  |  Financial News

Migraine play CoLucid raises $37.1M

CoLucid Pharmaceuticals Inc. (Durham, N.C.) raised $37.1 million in a series C round led by TVM Capital Life Science. New investors included Novo Ventures and Auriga Partners. Existing investors Pappas Ventures; Domain Associates; Care Capital;...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Financial News

Median Technologies proposes private placement of units

Median Technologies Inc. (Euronext:ALMDT), Valbonne, France   Business: Diagnostic   Date announced: 2014-08-25   Type: Private placement of units   To be raised: EUR20 million ($26.8 million)   Units: 2.2 million   Price: EUR9 (unit)...